No abstract available
MeSH terms
-
Cerebrovascular Disorders / etiology
-
Cerebrovascular Disorders / prevention & control
-
Coronary Disease / etiology*
-
Coronary Disease / prevention & control
-
Diabetic Angiopathies / etiology*
-
Diabetic Angiopathies / prevention & control*
-
Diabetic Nephropathies / etiology*
-
Diabetic Nephropathies / prevention & control*
-
Dyslipidemias / complications*
-
Dyslipidemias / metabolism
-
Fenofibrate / administration & dosage
-
Glomerular Filtration Rate
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
-
Hypolipidemic Agents / administration & dosage
-
Insulin / physiology
-
Risk Factors
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Hypolipidemic Agents
-
Insulin
-
Fenofibrate